FDA Investigator Nancy E Byerly

Nancy E Byerly has conducted inspections on 285 sites in 1 countries as of 07 Jun 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
285
Last Inspection Date:
07 Jun 2017
Investigator Role:
FDA Investigator
Redica ID:
100004231
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Nancy E Byerly:
Aaron J Poloni, Abby M Miller, Abigail A Andersen, Aileen Santos, Alan D Grupe, Alexandra B Pitkin, Amber M Howell, Andrew K Haack, PhD, Andrew S Johnson, Anh Trinh T Nguyen, Anita Narula, PhD, Annette L Diggs, Anthony G Emerson, Astrida B Mattson, Ava M Bowman, Avery J Dennis, Ayodele I Ojediran, Babajide Michael Osunsanmi, Barbara J Rincon, Barbara Janine Breithaupt, Binh T Nguyen, Bonnie I Needleman, Brenda K Alford, Brenda L Reihing, Brian E Thompson, Brian P Putz, Brian Ravitch, Bruce R Burrell, Bryan L Maguckin, Bryan L Mcguckin, Bryce A May, Bryce E Mansfield, Bush, Camille Bennett Hoffman, Carl A Anderson, Carla M Fernandez Borges, Caryn M Mcnab, Catherine J Laufmann, Cathleen A Carr Sharpe, Ce'nedra M Martin, Celena Ngo, Celia L Hutchinstein, Christopher M Hernandez, Christopher R Czajka, Comyar Shoghi, Connie P Rezendes, Courtney R Ingalsbe, Crystal A Harlan, Cynthia L Gorveatt, Daniel W Cline, Darren S Brown, David A Quale, David H Hsu, David J Gomes, David Serrano, David Y Hernandez, Davis, Dawn E Barkans, Deborah A Greco, Deborah A Nebenzahl, Debra D Devlieger, Debra J Fracassa, Desiree C Iya, Devon M Shoop, Diana M Rand, Dirk L Lincoln, Dogbeda F Mackenzie, Donald B Mckechnie, Donna Ltartaglino Besone, Douglas J Scott, Durell L Giles, Edward D Harris, Eileen T Dupont, Elizabeth A Sheller, Elizabeth S Howell, Ellen N Stewart, Ellen Stewart, Eric L Scott, Erica L Nicoll, Erika V Butler, Farhana Khan, Feliser V Hilario, Francisco, Garciam, Garrad R Poole, Gary C Pecic, Jr, Gavin T Cua, Gavin W Pierce, Gerard Pde Leon, Gloria J Baca, MS, Grace P Santos, Greg K Keshishyan, Harmon M Blanch, Heika R Tait, Henry E Carrillo, Herminio C Francisco, Hugh A Grimoldby, Hung V Le, Ian J Thomson, Jacob N Hamilton, James C Henry, James D Hildreth, James E Trabert, James I Vik, James S Cartwright, Jane M Kreis, Jasmine N Thompson, Jason T Lovelady, Jean C Colon Lopez, Jean R Mccurry, Jeanne M Weishaar, Jeannie Pradyanata, Jeff M Uriarte, Jeffrey J Leclair, Jeffrey N Gerdes, Jennifer A Robinson, Jennifer L Blanck, Jennifer W Cheng Dobson, Jessica B Clark, Jessica B Zachman, Jessica L Kocian, Jessie J Deloach, Jim D Pressley, Jinkee Mvila Binayug, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel D Hustedt, Joey V Quitania, John A Daubenspeck, John A Gonzalez, Jolanna A Norton, Jonathan T Little, Jose O Caraballo Rivera, Joshua P Wireman, Judy C Nepsa, Julia Ventura, Julian C Hanson, Julie A Stocklin, Katelyn Astaub Zamperini, Katharine Chan, Katherine L Arnold, Katherine L Ernest, Kawshalya Pathiraja, Keegan B Mixon, Keishla M Arroyo Lopez, Kelley, Kelsey A Hustedt, Kelsey A Volkman, Kelsey M Bishop, Kenneth O Gee, PhD, Kevin Lee, Kevin T Gerrity, Kham Phommachanh, Khanh T Van, Khoa Nathanv Tran, Kimberly Jproctor Jones, Kimberly M Lichter, Kirsten S Tharp, Kristina M Phelps, Lance W Bohm, Lanita F Kelley, Lata C Mathew, PhD, Lawrence Y Lee, PhD, LCDR Ismael Olvera, IV, LCDR Wilfred A Darang, Lenita R Silvera, Lesley A Swanson, Leya A Grosch, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda S Leja, Lisa A Bowden, Lisa H Nakagawa, Lisa K Capron, Lisa T Michel, Lori J Silverstein, Louis B Cencetti, Lucy Severs, Lynda L Perry, PhD, Lynette M Terry, Malinda C Shelman, Margo C Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mark C Saale, Mark E Imsland, Mark E Moen, Mark S Crippen, Marsha L Mccauley, Matthew J Johnson, Matthew R Barr, Michael D Garcia, Michael J Donovan, Michael S Hudson, Michael S Valenzuela, Michelle J Hines, Michelle S Swanson, Mihaly S Ligmond, Mikel T Wright, Misty L Wallace, Nancy A Saxenian Emmons, Nancy E Doyle, Nancy E Smith, Narahi J Alvarez Alcazar, Natalie J Ayoub, Nataniel Phillips Sylvain, PhD, Naveen B Walker, Neil J Traaen, Nianna C Burns, Nicholas J Lahey, Othello G Capangpangan, Paul F Rader, Paul M Kawamoto, Paula J Wilkerson, Peter Kessler, PhD, Peter T Regan, Phal K Chhun, Philip E Ake, Phillip J Dugger, Phillip J Sample, Phillip L Toy, Rachel J Cantrell, Randy L Elsberry, Rebecca A Sletner, Rebecca T Davis, Richard A Martin, Richard G Runyon, Richard W Tubb, Robert C Hoover, Robert D Tollefsen, Robert T Lorenz, Rocco C Black, Rochelle A Rolnik, Roger F Zabinski, Ronald E Gill, Russell R La Claire, S Lori Brown, PhD MPH, Sabrina J Dethloff, Sandra K Wangen, Sangeeta M Khurana, PhD, Sara Jdent Acosta, Sarah A Hassas, Sarah L Clark, Scott N Lim, Scott W Fox, Sean P Desbrow, Selene T Torres, Shahriar Rahmani, Shannon J Hall, Shelagh D Schopen, Sherri N Rohlf, MD, Sonia R Peterson, Sonya L Karsik, RAC, Stacy A Schneider, Stanley B Eugene, BS, BME, Stephanie A Jameson, Stephanie A Slater, MS, Stephanie J Shaw, Steven E Porter, Jr, Sundy V Sedwick, Sunitha K Rajaram, PhD, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tara A Marshall, Tara M Pianko, Tawny L Colling, Thao T Kwan, Thomas C Mclean, CFS, Thomas R Beilke, Timothy D Evans, Timothy P Lafave, Tracy K Li, Truong Xuan Nguyen (Andy), Trushani T Desai, Tuan D Tran, Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa Y Gelsey, PhD, Vickie L Anderson, Victor H Loo, Virgilio F Pacio, CSO, Vitaliy N Guyvan, Wendy S Antonowsky, William A Burkey, Willis L Hicks, Wolfgang F Povolny, Yvette Mlacour Davis, Yvonne T Lacour, Zachary A Bogorad, Zachary P Wachlarowicz

Nancy E Byerly's Documents

Publish Date Document Type Title
July, 2015 FDA 483 HTO Nevada, Inc. (dba Kirkman) - Form 483, 2015-07-15
June, 2014 FDA 483 Lincare - Form 483, 2014-06-04
July, 2016 FDA 483 Response Trone Health Services, Inc. - Form 483R, 2016-08-03
April, 2017 FDA 483 Response Hemcare of Oregon, Inc. - Form 483R, 2017-05-26
July, 2015 FDA 483 Kirkman Laboratories, Inc. - Form 483, 2015-07-15
March, 2017 FDA 483 Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center - Form 483, 2017-03-08
December, 2004 FDA 483 Bakery Express - Form 483, 2004-12-14
January, 2016 FDA 483 MakingCosmetics Inc. - Form 483, 2016-01-15
March, 2003 EIR Anacapa Technologies, Inc - EIR, 2003-03-19
March, 2012 EIR Skin Biology Inc - EIR, 2012-03-30
September, 2016 FDA 483 Ladd Family Pharmacy LLC - Form 483, 2016-09-23
January, 2011 FDA 483 Aidapak Services, LLC - Form 483, 2011-01-06
May, 2011 EIR Transitions For Health Inc - EIR, 2011-05-05
March, 2016 FDA 483 Center for Life, Inc. - Form 483, 2016-03-22
May, 2009 FDA 483 Mountain Meadow Herbs, Inc. - Form 483, 2009-05-15
April, 2013 FDA 483 Skin Biology Inc - Form 483, 2013-04-11
May, 2011 FDA 483 Transitions For Health Inc - Form 483, 2011-05-05
July, 2016 FDA 483 Trone Health Services, Inc. - Form 483, 2016-07-15
November, 2015 EIR Paula's Choice LLC - EIR, 2015-11-13
February, 2014 FDA 483 Formula Corp. - Form 483, 2014-02-14
January, 2000 FDA 483 American International Industries - Form 483, 2000-01-25
February, 2012 FDA 483 Apria Healthcare LLC - Form 483, 2012-02-07
July, 2009 EIR Transitions For Health Inc - EIR, 2009-07-23
March, 2002 FDA 483 Fusion Formulations LLC - Form 483, 2002-03-25
January, 2013 EIR Hemcare of Oregon, Inc. - EIR, 2013-01-07
March, 2003 FDA 483 Anacapa Technologies, Inc - Form 483, 2003-03-19
July, 2009 FDA 483 Transitions For Health Inc - Form 483, 2009-07-23
April, 2017 FDA 483 Hemcare of Oregon, Inc. - Form 483, 2017-04-26
May, 2011 FDA 483 Response Transitions For Health Inc - Form 483R, 2011-05-27
March, 2003 FDA 483 Response Anacapa Technologies, Inc - Form 483R, 2003-03-24
May, 2012 FDA 483 Formula Corp. - Form 483, 2012-05-09
April, 2017 EIR Hemcare of Oregon, Inc. - EIR, 2017-04-26
June, 2015 FDA 483 Kirkman Laboratories, Inc. - Form 483, 2015-06-24
January, 2013 FDA 483 Hemcare of Oregon, Inc. - Form 483, 2013-01-07
October, 2009 FDA 483 Tec Laboratories, Inc. - Form 483, 2009-10-30
December, 2011 FDA 483 Solum & Herbe - Form 483, 2011-12-15
April, 2015 FDA 483 Episciences, Inc. - Form 483, 2015-04-10
April, 2015 EIR Episciences, Inc. - EIR, 2015-04-10
April, 2015 FDA 483 Response Episciences, Inc. - Form 483R, 2015-04-24
June, 2015 FDA 483 Response Kirkman Laboratories, Inc. - Form 483R, 2015-12-28
October, 2011 FDA 483 Tec Laboratories, Inc. - Form 483, 2011-10-28
January, 2010 FDA 483 HF Acquisition Co LLC - Form 483, 2010-01-19
March, 2012 FDA 483 Skin Biology Inc - Form 483, 2012-03-30
June, 2013 FDA 483 EarthLab Holdings Inc - Form 483, 2013-06-21
June, 2016 FDA 483 Gabriel Cosmetics Inc - Form 483, 2016-06-16
March, 2012 FDA 483 Response Skin Biology Inc - Form 483R, 2012-04-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more